Gregory Kato, MD, Hematology, King Of Prussia, PA

GregoryJamesKatoMD

Hematology King Of Prussia, PA

Sickle Cell & Other Anemias

Senior Director, Global Clinical Programs, Clinical Research and Development, Hematology Therapeutic Area

Dr. Kato is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Kato's full profile

Already have an account?

Summary

  • I am a hematologist with an active translational research interest in sickle cell disease, especially how intravascular hemolysis affects the complications of sickle cell disease. My past research experience includes blood flow physiology studies, clinical trials and proteomic analysis of plasma to unravel new mechanisms contributing to pulmonary hypertension and other complications of sickle cell disease. We have formulated a model to suggest that pulmonary hypertension, stroke, leg ulcers and priapism share features of vasculopathy.

    After 29 years of patient care, clinical research and molecular biology laboratory research, I have taken a role in the biotech industry to develop new therapeutics for sickle cell disease and other blood disorders.

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFELLOWSHIP
  • Children's Hospital of Los Angeles
    Children's Hospital of Los AngelesRESIDENCY
  • George Washington University School of Medicine
    George Washington University School of MedicineMEDICAL_SCHOOL

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 2013 - 2020
  • DC State Medical License
    DC State Medical License 2003 - 2008
  • MD State Medical License
    MD State Medical License 1988 - 2014
  • American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • A Phase II Trial of Topical Sodium Nitrite in Patients with Sickle Cell Disease and Leg Ulcers
    Gregory J Kato, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Impaired Bile Secretion Promotes Chronic Liver Injury in Sickle Cell Disease
    Gregory J Kato, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • A Prospective Phase II, Open-Label, Single-Arm, Multicenter Study to Assess the Efficacy and Safety of SEG101 (Crizanlizumab) in Sickle Cell Disease Patients with Pria...
    Gregory J Kato, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Join now to see all

Lectures

  • Disease Modification in Sickle Cell Disease: Mechanisms, Advances and Clinical Implications 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Authored Content

  • Sickle Cell DiseaseMarch 2018

Grant Support

  • Use Of Hydroxyurea &L-Arginine Or Sildenafil In Patients W/Sickle Cell DiseaseNational Heart, Lung, And Blood Institute2009–2011
  • Treatment Of PH And SCD With Sildenafil TherapyNational Heart, Lung, And Blood Institute2009–2011
  • Therapeutic Application Of Intravascular Nitrite For Sickle Cell DiseaseNational Heart, Lung, And Blood Institute2009–2011
  • Systemic Nitrite Infusion And Its Effect On Exercise Physiology And MetabolismNational Heart, Lung, And Blood Institute2009–2011
  • Synergy Of Hydroxyurea And Erythropoietin On Fetal Hemoglobin In SCDNational Heart, Lung, And Blood Institute2009–2011
  • Pulmonary Hypertension And The Hypoxic Response In SCD (PUSH)National Heart, Lung, And Blood Institute2009–2011
  • Prevalence Of PAH In SCD Patients In NigeriaNational Heart, Lung, And Blood Institute2009–2011
  • Nitric Oxide For Patients With Sickle Cell Anemia And Pulmonary HypertensionNational Heart, Lung, And Blood Institute2009–2011
  • Niacin Therapy To Improve Endothelial Function In SCDNational Heart, Lung, And Blood Institute2009–2011
  • Natural History Of Sickle Cell Disease And Other Hemolytic DisordersNational Heart, Lung, And Blood Institute2009–2011
  • Multicenter Trial Of NO For Acute Treatment Of Sickle Cell Pain EpisodesNational Heart, Lung, And Blood Institute2009–2011
  • Cardiopulmonary Function Assessment And NO Based Therapies For SCD PTS With PAHNational Heart, Lung, And Blood Institute2009–2011
  • Blood Studies Of Endothelial Function And Systemic InflammationNational Heart, Lung, And Blood Institute2009–2011
  • Atorvastatin Therapy To Improve Endothelial Function In Sickle Cell DiseaseNational Heart, Lung, And Blood Institute2009–2011
  • Use Of Bosentan In Patients With Symptomatic PH Associated With SCDNational Heart, Lung, And Blood Institute2009–2010
  • Nitrite Infusion Studies On Healthy VolunteersNational Heart, Lung, And Blood Institute2009
  • Therapeutic Application Of Intravascular Nitrite For SICClinical Center2006
  • Atorvastatin Therapy To Improve Endothelial Function InClinical Center2005–2006
  • Therapeutic Application Of Intravascular Nitrite For SCDClinical Center2005
  • Atorvastatin Endothelial Function In Sickle Cell DiseaseClinical Center2004
  • Atorvastatin Therapy And Endothelial Function In SCDClinical Center2003
  • Proteolysis Of Leukemia--Related Transcription FactorsNational Cancer Institute1996–2000
  • Transcriptional Activation Domain Of C-MYC ProteinNational Cancer Institute1992–1996
  • The Transcriptional Activation Domain Of C-MYC ProteinNational Cancer Institute1993

Professional Memberships

Other Languages

  • Spanish

Industry Relationships

  • Consultant, Biogen IdecDisclosure: Consulting fee2014 - 2015